# enVVeno Medical Corp: filings

NVNO · Nasdaq · CIK 1661053 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nvno.md) · [Financials](/companies/nvno/financials.md) · [Filings](/companies/nvno/filings.md) · [Insiders](/companies/nvno/insiders.md)

## Reports and events: 132 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 86, 8-K 57, CORRESP 28, 10-Q 26, 3 21, UPLOAD 20, EFFECT 15, S-1/A 14, 144 12, SC 13G/A 11, DEF 14A 10, SC 13G 10, FWP 9, 10-K 8, 424B5 8, S-1 8, D 6, S-3 6, S-8 6, SCHEDULE 13G/A 6, 424B4 5, SCHEDULE 13G 4, 3/A 3, 424B3 3, DEFA14A 3, S-3/A 3, 10-K/A 2, 4/A 2, DRS 2, POS AM 2, S-1MEF 2, SCHEDULE 13D 2, 10-Q/A 1, 25-NSE 1, 5 1, 8-A12B 1, 8-A12B/A 1, 8-K/A 1, CERT 1, D/A 1, DEFR14A 1, NT 10-Q 1, PRE 14A 1, PRER14A 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 17:00 ET | [DEF 14A](/filings/0001140361-26-041182.md) | Proxy statement, period 2026-12-10 | 0001140361-26-041182 |
| 2026-10-29 | 16:05 ET | [10-Q](/filings/0001493152-26-049269.md) | Quarterly report, period 2026-09-30 | 0001493152-26-049269 |
| 2026-09-15 | 16:01 ET | [SCHEDULE 13D/A](/filings/0001213900-26-100114.md) | Ownership report, active investor, amended | 0001213900-26-100114 |
| 2026-07-30 | 16:05 ET | [10-Q](/filings/0001493152-26-035452.md) | Quarterly report, period 2026-06-30 | 0001493152-26-035452 |
| 2026-07-14 | 16:55 ET | [8-K](/filings/0001493152-26-033193.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-033193 |
| 2026-05-06 | 16:10 ET | [10-Q](/filings/0001493152-26-021490.md) | Quarterly report, period 2026-03-31 | 0001493152-26-021490 |
| 2026-04-29 | 08:25 ET | [8-K](/filings/0001493152-26-019485.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-019485 |
| 2026-03-26 | 16:24 ET | [10-K](/filings/0001493152-26-012928.md) | Annual report, period 2025-12-31 | 0001493152-26-012928 |
| 2026-02-20 | 09:43 ET | [SCHEDULE 13D](/filings/0001213900-26-018626.md) | Ownership report, active investor | 0001213900-26-018626 |
| 2026-02-20 | 09:43 ET | [SCHEDULE 13D](/filings/0001213900-26-018625.md) | Ownership report, active investor | 0001213900-26-018625 |
| 2026-02-04 | 08:30 ET | [8-K](/filings/0001493152-26-005030.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-005030 |
| 2026-01-20 | 16:10 ET | [8-K](/filings/0001493152-26-002860.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-002860 |
| 2025-12-12 | 16:05 ET | [8-K](/filings/0001493152-25-027482.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-027482 |
| 2025-11-20 | 17:18 ET | [8-K](/filings/0001493152-25-024494.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-024494 |
| 2025-11-14 | 21:29 ET | [8-K](/filings/0001493152-25-022440.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022440 |
| 2025-10-30 | 17:28 ET | [8-K](/filings/0001493152-25-020276.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-020276 |
| 2025-10-30 | 16:16 ET | [DEF 14A](/filings/0001140361-25-039863.md) | Proxy statement, period 2025-12-11 | 0001140361-25-039863 |
| 2025-10-30 | 16:06 ET | [10-Q](/filings/0001493152-25-020215.md) | Quarterly report, period 2025-09-30 | 0001493152-25-020215 |
| 2025-10-10 | 06:30 ET | [8-K](/filings/0001493152-25-017691.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-25-017691 |
| 2025-08-20 | 07:10 ET | [8-K](/filings/0001493152-25-012181.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-012181 |
| 2025-07-31 | 16:25 ET | [10-Q](/filings/0001493152-25-011521.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011521 |
| 2025-05-20 | 16:30 ET | [8-K](/filings/0001641172-25-011729.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-011729 |
| 2025-04-30 | 17:28 ET | [10-Q](/filings/0001641172-25-007908.md) | Quarterly report, period 2025-03-31 | 0001641172-25-007908 |
| 2025-04-21 | 16:05 ET | [8-K](/filings/0001641172-25-005547.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-005547 |
| 2025-02-28 | 17:23 ET | [10-K/A](/filings/0001493152-25-008739.md) | Annual report, amended, period 2024-12-31 | 0001493152-25-008739 |
| 2025-02-28 | 21:37 ET | [10-K](/filings/0001493152-25-008581.md) | Annual report, period 2024-12-31 | 0001493152-25-008581 |
| 2024-12-26 | 19:10 ET | [8-K](/filings/0001493152-24-051926.md) | 5.07 Shareholder vote results | 0001493152-24-051926 |
| 2024-11-19 | 16:45 ET | [DEF 14A](/filings/0001140361-24-047305.md) | Proxy statement, period 2024-12-18 | 0001140361-24-047305 |
| 2024-10-31 | 19:20 ET | [10-Q](/filings/0001493152-24-043100.md) | Quarterly report, period 2024-09-30 | 0001493152-24-043100 |
| 2024-09-30 | 17:05 ET | [8-K](/filings/0001493152-24-038828.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-038828 |
| 2024-07-31 | 16:05 ET | [10-Q](/filings/0001493152-24-029737.md) | Quarterly report, period 2024-06-30 | 0001493152-24-029737 |
| 2024-05-08 | 16:05 ET | [10-Q](/filings/0001493152-24-018225.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018225 |
| 2024-04-24 | 06:15 ET | [8-K](/filings/0001493152-24-015752.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-015752 |
| 2024-03-06 | 08:40 ET | [8-K](/filings/0001493152-24-008950.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-008950 |
| 2024-02-29 | 16:29 ET | [10-K](/filings/0001493152-24-008336.md) | Annual report, period 2023-12-31 | 0001493152-24-008336 |
| 2023-12-07 | 16:05 ET | [8-K](/filings/0001493152-23-044010.md) | 5.07 Shareholder vote results | 0001493152-23-044010 |
| 2023-11-16 | 08:45 ET | [8-K](/filings/0001493152-23-041594.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-041594 |
| 2023-11-03 | 16:05 ET | [DEF 14A](/filings/0001493152-23-039303.md) | Proxy statement, period 2023-11-03 | 0001493152-23-039303 |
| 2023-10-26 | 17:58 ET | [10-Q](/filings/0001493152-23-038302.md) | Quarterly report, period 2023-09-30 | 0001493152-23-038302 |
| 2023-10-12 | 17:00 ET | [8-K](/filings/0001493152-23-037065.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-037065 |
| 2023-07-31 | 16:30 ET | [10-Q](/filings/0001493152-23-026085.md) | Quarterly report, period 2023-06-30 | 0001493152-23-026085 |
| 2023-04-28 | 16:05 ET | [10-Q](/filings/0001493152-23-014683.md) | Quarterly report, period 2023-03-31 | 0001493152-23-014683 |
| 2023-03-02 | 16:47 ET | [10-K](/filings/0001493152-23-006587.md) | Annual report, period 2022-12-31 | 0001493152-23-006587 |
| 2022-12-06 | 16:15 ET | [8-K](/filings/0001493152-22-034589.md) | 5.07 Shareholder vote results | 0001493152-22-034589 |
| 2022-11-01 | 17:29 ET | [DEF 14A](/filings/0001493152-22-030124.md) | Proxy statement, period 2022-11-01 | 0001493152-22-030124 |
| 2022-10-27 | 16:05 ET | [10-Q](/filings/0001493152-22-029717.md) | Quarterly report, period 2022-09-30 | 0001493152-22-029717 |
| 2022-08-03 | 16:26 ET | [10-Q](/filings/0001493152-22-021166.md) | Quarterly report, period 2022-06-30 | 0001493152-22-021166 |
| 2022-05-11 | 16:15 ET | [10-Q/A](/filings/0001493152-22-012858.md) | Quarterly report, amended, period 2022-03-31 | 0001493152-22-012858 |
| 2022-05-11 | 16:10 ET | [10-K/A](/filings/0001493152-22-012855.md) | Annual report, amended, period 2021-12-31 | 0001493152-22-012855 |
| 2022-04-29 | 16:41 ET | [10-Q](/filings/0001493152-22-011591.md) | Quarterly report, period 2022-03-31 | 0001493152-22-011591 |

Page 1 of 3. [Older](/companies/nvno/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 19:27 ET. No prices; not investment advice.